Neurocrine Biosciences Inc (NAS:NBIX)
$ 141.08 -0.92 (-0.65%) Market Cap: 14.20 Bil Enterprise Value: 13.60 Bil PE Ratio: 38.87 PB Ratio: 5.95 GF Score: 89/100

Neurocrine Biosciences Inc at Jefferies London Healthcare Conference Transcript

Nov 20, 2019 / 10:00AM GMT
Release Date Price: $113.08 (+0.31%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Great. Let's get started. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to introduce our next company. We have Neurocrine Biosciences. Next to me is their CEO, Kevin Gorman; and we have the company's CFO, Matt Abernethy. And before -- this is going to be a fireside chat format. So before we start Q&A, Kevin, I want to thank you for changing my name on the last conference call to Anupam. My mom always dreamed of naming me Anupam. So you fulfilled her dream.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

I deserve that. I only called you Anupam 4 times.

Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Yes, exactly.

Questions & Answers

Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

So -- well, getting down to the side of things, let's talk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot